• 86 Hits
  • Search Condition : Filter (MeSH = Imidazoles / pharmacology)
Species Resource Title
Human and Animal Cells ME-180(RCB2160) , Ca Ski(RCB1947) Targeting the mutant PIK3CA gene by DNA-alkylating pyrrole-imidazole polyamide in cervical cancer.
DNA material pJNC-hINS-GLuc (RDB19845) Video rate bioluminescence imaging of secretory proteins in living cells: localization, secretory frequency, and quantification.
Human and Animal Cells ST2(RCB0224) Transforming growth factor-beta induces expression of receptor activator of NF-kappa B ligand in vascular endothelial cells derived from bone.
Human and Animal Cells L929 Rac is activated by tumor necrosis factor alpha and is involved in activation of Erk.
Human and Animal Cells DAUDI(RCB1640) Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain.
Human and Animal Cells A549(RCB0098) Upregulation of Chemoresistance by Mg2+ Deficiency through Elevation of ATP Binding Cassette Subfamily B Member 1 Expression in Human Lung Adenocarcinoma A549 Cells.
Human and Animal Cells JHOM-1(RCB1676) , JHOM-2B(RCB1682) Dual inhibition of phosphatidylinositol 3'-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach for mucinous adenocarcinoma of the ovary.
Human and Animal Cells Ba/F3-CL1(RCB4474) Targeting anaplastic lymphoma kinase (ALK) gene alterations in neuroblastoma by using alkylating pyrrole-imidazole polyamides.
Human and Animal Cells 585A1(HPS0354) , 648A1(HPS0360) Disease modeling of pulmonary fibrosis using human pluripotent stem cell-derived alveolar organoids.
Human and Animal Cells HuH-7 mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.
Human and Animal Cells RAW 264(RCB0535) Oral malodorous compound induces osteoclast differentiation without receptor activator of nuclear factor κB ligand.
Human and Animal Cells ST2(RCB0224) MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
Human and Animal Cells Ba/F3(RCB0805) TKI-addicted ROS1-rearranged cells are destined to survival or death by the intensity of ROS1 kinase activity.
Human and Animal Cells ACC-MESO-1(RCB2292) , ACC-MESO-4(RCB2293) Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells.
Human and Animal Cells B16 melanoma(RCB1283) Tokoronin Contained in Dioscorea tokoro Makino ex Miyabe Suppressed α-MSH-Induced Melanogenesis in B16 Cells via Suppression of Classical MAPK Pathway Activation.
Human and Animal Cells NALM-6(RCB1933) , CCRF-CEM(RCB1980) A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
Human and Animal Cells JHOC-7(RCB1688) , JHOC-9(RCB2226) Effect of murine double-minute 2 inhibitors in preclinical models of advanced clear cell carcinomas originating from ovaries and kidneys.
Human and Animal Cells PC-9(RCB4455) Transient IGF-1R inhibition combined with osimertinib eradicates AXL-low expressing EGFR mutated lung cancer.
Human and Animal Cells HL60(RCB0041) , U-937 DE-4(RCB0435) Nitrogen-containing bisphosphonates induce apoptosis of hematopoietic tumor cells via inhibition of Ras signaling pathways and Bim-mediated activation of the intrinsic apoptotic pathway.
Human and Animal Cells RAW 264(RCB0535) Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).